Aslan Pharms (ASLN) Stock Price, News & Analysis
Company Description
Aslan Pharms (NASDAQ: ASLN) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector and carries a market capitalization of $1.7M, ranking #7,199 among all listed U.S. companies by market cap.
ASLN has declined 96.5% over the past year. Shares last traded at $0.6000.
This page collects what Stock Titan holds for ASLN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Aslan Pharms (ASLN) stock last traded at $0.6000. Over the past 12 months, the stock has lost 96.5%. At a market capitalization of $1.7M, ASLN is classified as a micro-cap stock with approximately 2.8M shares outstanding.
ASLN Rankings
Latest News
Aslan Pharms has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, clinical trial. View all ASLN news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ASLN Company Profile & Sector Positioning
Aslan Pharms (ASLN) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.